Concepedia

Therapy Switching

Therapy Switching is a clinical decision-making strategy in osteoporosis pharmacotherapy wherein a patient’s treatment regimen is sequentially changed from one pharmacological agent to another, primarily to enhance efficacy, mitigate adverse effects, or overcome therapeutic failure.

96

Publications

3.8K

Citations

628

Authors

325

Institutions

Publications per year

2017–2026

42

Parents

Publications

96

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

Benjamin Z. Leder, Joy N. Tsai, Alexander V. Uihlein et al. · The Lancet · 2015 · 576 citations

, , +13

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis

S. ten Wolde, F. C. Breedveld, Ben A. C. Dijkmans et al. · The Lancet · 1996 · 163 citations

, , +9

Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study

K. M. Fagerli, Elisabeth Lie, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2013 · 132 citations

, , +13

Resistance of rheumatoid arthritis patients to changing therapy: Discordance between disease activity and patients' treatment choices

Frederick Wolfe, Kaleb Michaud · Arthritis & Rheumatism · 2007 · 131 citations

, , +11

Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study

James P. Morden, Paul C. Lambert, Nicholas Latimer et al. · BMC Medical Research Methodology · 2011 · 117 citations · Full text

, , +15

1–5 of 96

Authors

628

  1. JR
    Jeffrey R. Curtis

    University of Alabama at Birmingham, United States

    5 publications · 210 citations

    5

    h-index

  2. MH
    Makoto Hirao

    The University of Osaka, Japan

    4 publications · 138 citations

    4

    h-index

  3. CC
    Chieh-I Chen

    Regeneron (United States), United States

    4 publications · 123 citations

    4

    h-index

  4. JH
    Jun Hashi­moto

    The University of Osaka, Japan

    4 publications · 138 citations

    4

    h-index

  5. HY
    Hideki Yoshikawa

    The University of Osaka, Japan

    4 publications · 138 citations

    4

    h-index

1–5 of 628

Institutions

325

  1. Regeneron (United States)

    Tarrytown, United States

    6 h-index

    10 publications

    261 citations

  2. Sanofi (United States)

    Bridgewater, United States

    6 h-index

    9 publications

    220 citations

  3. University of Alabama at Birmingham

    Birmingham, United States

    5 h-index

    16 publications

    666 citations

  4. Pfizer (United States)

    New York, United States

    4 h-index

    7 publications

    255 citations

  5. Harvard University

    Cambridge, United States

    4 h-index

    13 publications

    3.7K citations

  6. The University of Osaka

    Osaka, Japan

    4 h-index

    23 publications

    797 citations

  7. Osaka Minami Medical Center

    Osaka, Japan

    4 h-index

    5 publications

    165 citations

  8. Universitat Autònoma de Barcelona

    Cerdanyola del Vallès, Spain

    3 h-index

    9 publications

    499 citations

1–8 of 325

Venues

  1. Lara D. Veeken

    6 publications · 181 citations

    6

    h-index

  2. Journal of Bone and Mineral Metabolism

    5 publications · 179 citations

    5

    h-index

  3. PubMed

    Repository · 5 publications · 102 citations

    5

    h-index

  4. Osteoporosis International

    5 publications · 138 citations

    5

    h-index

  5. Arthritis Care & Research

    4 publications · 102 citations

    4

    h-index

1–5